Company news and developments, with original sources and dates.
Updated from source·Oct 20, 2026, 18:05 UTC
On September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela.